As of 2025-05-15, the EV/EBITDA ratio of InspireMD Inc (NSPR) is -1.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NSPR's latest enterprise value is 53.39 mil USD. NSPR's TTM EBITDA according to its financial statements is -31.67 mil USD. Dividing these 2 quantities gives us the above NSPR EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.2x - 6.9x | 5.2x |
| Forward P/E multiples | 5.2x - 7.3x | 6.5x |
| Fair Price | (4.76) - (6.51) | (5.43) |
| Upside | -301.6% - -376.0% | -330.0% |
| Date | EV/EBITDA |
| 2025-03-03 | -2.77 |
| 2025-02-28 | -2.52 |
| 2025-02-27 | -2.65 |
| 2025-02-26 | -2.65 |
| 2025-02-25 | -2.69 |
| 2025-02-24 | -2.98 |
| 2025-02-21 | -2.49 |
| 2025-02-20 | -2.40 |
| 2025-02-19 | -2.40 |
| 2025-02-18 | -2.18 |
| 2025-02-14 | -2.26 |
| 2025-02-13 | -2.17 |
| 2025-02-12 | -2.12 |
| 2025-02-11 | -2.12 |
| 2025-02-10 | -2.29 |
| 2025-02-07 | -2.07 |
| 2025-02-06 | -1.94 |
| 2025-02-05 | -2.10 |
| 2025-02-04 | -1.95 |
| 2025-02-03 | -1.82 |
| 2025-01-31 | -1.90 |
| 2025-01-30 | -1.89 |
| 2025-01-29 | -1.75 |
| 2025-01-28 | -1.87 |
| 2025-01-27 | -2.02 |
| 2025-01-24 | -2.14 |
| 2025-01-23 | -2.20 |
| 2025-01-22 | -2.07 |
| 2025-01-21 | -2.25 |
| 2025-01-17 | -2.04 |
| 2025-01-16 | -2.00 |
| 2025-01-15 | -2.00 |
| 2025-01-14 | -1.99 |
| 2025-01-13 | -1.97 |
| 2025-01-10 | -2.07 |
| 2025-01-08 | -2.08 |
| 2025-01-07 | -2.02 |
| 2025-01-06 | -2.08 |
| 2025-01-03 | -2.02 |
| 2025-01-02 | -1.98 |
| 2024-12-31 | -1.95 |
| 2024-12-30 | -1.96 |
| 2024-12-27 | -2.01 |
| 2024-12-26 | -2.18 |
| 2024-12-24 | -2.17 |
| 2024-12-23 | -2.26 |
| 2024-12-20 | -2.31 |
| 2024-12-19 | -2.29 |
| 2024-12-18 | -2.20 |
| 2024-12-17 | -2.21 |